KeepitRealCrypto
697 posts













🚨BREAKING: 2.23 Million-Person Study Finds Pneumococcal Vaccines INCREASE Risk of Pneumonia and Death The vaccines given to nearly EVERY U.S. child and senior were linked to higher pneumonia and death rates in one of the largest real-world studies ever conducted ⬇️ ⚠️PCV13 Risks: +83% pneumococcal pneumonia, +55% all-cause pneumonia, +91% pneumonia death ⚠️PPSV23 Risks: +21% pneumococcal pneumonia, +24% all-cause pneumonia, no reduction in mortality Rather than preventing pneumonia, the vaccines were linked to a measurable increase in pneumonia hospitalizations and deaths. Even after adjusting for age, comorbidities, and influenza vaccination, both PCV13 and PPSV23 remained independently associated with poor outcomes. The authors concluded these results “raise serious concerns about effectiveness and public health impact” of adult pneumococcal vaccination programs. Although newer PCV15, PCV20, and PCV21 have replaced PCV13 in the U.S., they are built on the same platform—containing all PCV13 serotypes plus more, using the same CRM197 carrier protein and aluminum adjuvant system. Since 2010, PCV13 has been given to tens of millions of Americans, forming the backbone of the national pneumococcal vaccination program, while PPSV23 remains in use today. Those who previously received PCV13 or PPSV23 may face the same elevated risks of pneumonia and death—and these risks could persist or even amplify under the newer PCV15, PCV20, and PCV21 formulations.












